Acute treatment of Huntington's chorea with lisuride
- PMID: 6222164
- DOI: 10.1016/0022-510x(83)90042-4
Acute treatment of Huntington's chorea with lisuride
Abstract
The authors studied the effects of lisuride hydrogen maleate (lisuride) on the hyperkinesias of 11 patients suffering from Huntington's chorea (HC). In all patients, acute injection of 150 micrograms of the drug induced a marked temporary improvement of the abnormal involuntary movements; the favourable drug-effect was more pronounced in the patients with a less severe degree of hyperkinesia. The antichoreic activity of the drug was prevented by pretreatment with haloperidol (2 mg) or sulpiride (400 mg), both injected intramuscularly 30 min before lisuride administration. The authors suggest the improvement of the motor disturbance induced in HC by lisuride may be explained on the basis of its preferential action on a subset of brain dopaminergic receptor.
Similar articles
-
Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.Arch Neurol. 1978 Jan;35(1):27-30. doi: 10.1001/archneur.1978.00500250031006. Arch Neurol. 1978. PMID: 145840 Clinical Trial.
-
Effects of terguride in patients with Huntington's disease.Clin Neuropharmacol. 1989 Oct;12(5):435-9. doi: 10.1097/00002826-198910000-00008. Clin Neuropharmacol. 1989. PMID: 2575450 Clinical Trial.
-
Therapeutic experience with transdihydrolisuride in Huntington's disease.Neurology. 1986 Jul;36(7):984-6. doi: 10.1212/wnl.36.7.984. Neurology. 1986. PMID: 2940475 Clinical Trial.
-
Responses to lisuride in Meige's disease and chorea.Neurology. 1986 Mar;36(3):445. doi: 10.1212/wnl.36.3.445-a. Neurology. 1986. PMID: 2936984 Clinical Trial. No abstract available.
-
Treatment of Huntington's chorea with bromocriptine.Acta Neurol Scand. 1977 Jul;56(1):37-45. doi: 10.1111/j.1600-0404.1977.tb01407.x. Acta Neurol Scand. 1977. PMID: 141860 Clinical Trial.
Cited by
-
Treatment of Huntington's disease.Neurotherapeutics. 2014 Jan;11(1):153-60. doi: 10.1007/s13311-013-0244-z. Neurotherapeutics. 2014. PMID: 24366610 Free PMC article. Review.
-
Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.Front Neurosci. 2013 Jul 4;7:114. doi: 10.3389/fnins.2013.00114. eCollection 2013. Front Neurosci. 2013. PMID: 23847463 Free PMC article.
-
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.Neuropsychiatr Dis Treat. 2010 Oct 5;6:657-65. doi: 10.2147/NDT.S6430. Neuropsychiatr Dis Treat. 2010. PMID: 20957126 Free PMC article.
-
Advances in the pharmacological management of Huntington's disease.Drugs. 2010 Mar 26;70(5):561-71. doi: 10.2165/11534430-000000000-00000. Drugs. 2010. PMID: 20329804 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical